Skip to main content
. 2023 Apr 10;14:2020. doi: 10.1038/s41467-023-37785-2

Fig. 3. CAR T cells are repeatedly re-challenged with Nalm6 tumor cells in vitro.

Fig. 3

Different doses of HIP CAR T cells, allo CAR T cells, or Mock T cells were used as effectors against Nalm6 target cells in impedance cytotoxicity assays (mean ± SD, three independent replicates per group and time point in one experiment). The T cells were recovered daily and used as effector cells in new wells with Nalm6 target cells for 4 days. There was no difference in cytotoxicity between the two CAR groups at the same dose level.